Skip to content

Clinical trials

Recruiting Phase 1 Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1 Status: Recruiting Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
20201
20211
20233
20249
202513
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Innovent Biologics (Suzhou) Co. Ltd.2
Memorial Sloan Kettering Cancer Center2
National Cancer Institute (NCI)2
Sichuan Baili Pharmaceutical Co., Ltd.2
Suzhou Zelgen Biopharmaceuticals Co.,Ltd2
AstraZeneca1
Avacta Life Sciences Ltd1
Boehringer Ingelheim1
CSPC Megalith Biopharmaceutical Co.,Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma44
Carcinoma, Non-Small-Cell Lung12
Triple Negative Breast Neoplasms8
Endometrial Neoplasms7
Ovarian Neoplasms7
Colorectal Neoplasms6
Squamous Cell Carcinoma of Head and Neck6
Carcinoma, Neuroendocrine5
Neoplasm Metastasis5
Stomach Neoplasms5

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.